SCHEMBL7377644

SCHEMBL7377644

CC1(C(=O)O)CC(CN)CO1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.34
PLG P00747 1/20 0.34
PLAT P00750 1/20 0.34
ARG1 P05089 2/20 0.32
ARG2 P78540 2/20 0.32
MAPK1 P28482 2/20 0.31
TP53 P04637 1/20 0.31
NFKB1 P19838 1/20 0.31
CYP2C19 P33261 1/20 0.31
THPO P40225 1/20 0.31
STAT6 P42226 1/20 0.31
HIF1A Q16665 1/20 0.31
NPC1 O15118 1/20 0.31
GMNN O75496 1/20 0.31
MTOR P42345 1/20 0.31
RAB9A P51151 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7387353 0.83 MAPK1 (0.31) LMNAMAPK1TP53NFKB1CYP2C19
SCHEMBL28958153 0.75 CYP2C19 (0.33) LMNAMAPK1TP53NFKB1CYP2C19
Hydrochloric Acid SCHEMBL28879075 0.73 MAPK1 (0.32) LMNAMAPK1TP53NFKB1CYP2C19
SCHEMBL7382655 0.72 MAPK1 (0.34) LMNAMAPK1TP53NFKB1CYP2C19
SCHEMBL24230268 0.71
SCHEMBL13173136 0.71 MAPK1 (0.33) LMNAMAPK1TP53NFKB1CYP2C19
SCHEMBL7417087 0.71 ALDH1A1 (0.35) MAPK1CYP2C19
Ethylamine SCHEMBL21632440 0.67 FFAR3 (0.35) LMNAMAPK1TP53NFKB1CYP2C19
Acetic Acid SCHEMBL5042798 0.67 PLG (0.38) LMNAPLGPLATARG1ARG2
SCHEMBL3792829 0.66 CA2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420418-B1 INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE MERCK & CO., INC. 2002-07-16 US disclosed
WO-2001012183-A1 HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 2001-02-22 WO disclosed